TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...

The IMvigor010 trial showed that Signatera-guided treatment with Tecentriq improved disease-free survival and overall ...

Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders ...

The experts agreed that perioperative approaches in muscle-invasive bladder cancer continue to evolve. Ongoing data will ...

A new slow-release implant has shown unprecedented success in wiping out bladder cancer in more than 80 percent of patients, ...

The LEGEND trial showed a 62% complete response (CR) rate with the non-viral gene therapy at six months in NMIBC patients who ...

Mitchell, who has served as a councilman for 23 years, was diagnosed with bladder cancer in February after previously being ...

In Gaza, a patient’s suffering does not end at diagnosis. The Israeli blockade has turned obtaining any medical supplies into ...

An innovative new treatment option for bladder cancer, recently approved by the U.S. Food and Drug Administration, has been performed for the first time in Maryland.

A slow drug-release system has proven highly effective in treating certain bladder cancer patients whose tumors were previously unresponsive to therapy. A new targeted drug delivery system known as TA ...

Shannon Sharpe had just landed the job he’d spent years chasing, a dream co-hosting role with Skip Bayless on FS1, when a ...

A big-hearted, cancer-stricken Long Island jeweler has been jailed in Iran for the alleged crime of visiting Israel 13 years ...